See also this year's filing and all EDGAR filings for this company.
PDF Report 0001697805_2019_Xynomic_Pharmaceuticals_Holdings_INC.pdf
Logs
| warning | The EntityCommonStockSharesOutstanding does not exist | industry.us_generic | {} |
| warning | Missing logo | subcommand.report | {} |
Graph
Absolute values for 0001697805, Xynomic Pharmaceuticals Holdings INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 149,914 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 63,310,884 |
| 4 | LiabilitiesCurrent | 766,697 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 0 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 835,928 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | 1,102,554 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 63,460,798 |
| 1 | Liabilities | 766,697 |
| 2 | Expenses | 835,928 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 62,694,101 |
| 5 | NetIncome | 266,626 |
| 6 | ComprehensiveNetIncome | 266,626 |
| 7 | BaseVar | 33,082,988 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | 4.26 |
| 9 | EconomicCapitalRatio | 4.59 |
Edgar->Model Mapping
Feature Distribution
Change over Time
